An international qualitative study exploring patients’ experiences of cutaneous leishmaniasis: study set-up and protocol
Lack of investments in drug development, lack of standardisation of clinical trials and the complexity of disease presentations contribute to the current lack of effective, safe and adapted treatments for cutaneous leishmaniasis (CL). One aspect concerns outcomes affecting patients' quality of...
| Váldodahkkit: | , , , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Journal article |
| Giella: | English |
| Almmustuhtton: |
BMJ Publishing Group
2018
|